Miliku K, Voortman T, Franco O H, McGrath J J, Eyles D W, Burne T H, Hofman A, Tiemeier H, Jaddoe V W V
The Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Eur J Clin Nutr. 2016 May;70(5):629-34. doi: 10.1038/ejcn.2015.216. Epub 2015 Dec 23.
BACKGROUND/OBJECTIVES: Maternal vitamin D deficiency during pregnancy may influence offspring kidney health. We aimed to examine the associations of 25-hydroxyvitamin D (25(OH)D) blood levels during fetal life with kidney outcomes at school age.
SUBJECTS/METHODS: This study was embedded in a population-based prospective cohort study among 4212 mother-child pairs. We measured maternal second trimester (18-25 weeks) and fetal cord blood (at birth) 25(OH)D levels. At a median age of 6.0 years, we measured children's combined kidney volume, glomerular filtration rate (eGFR) from creatinine and cystatin C serum levels, and microalbuminuria from albumin and creatinine urine levels.
Of all mothers, 21.9% had severely deficient levels (25(OH)D <25.0 nmol/l), 25.7% had deficient levels (25.0-49.9 nmol/l), 25% had sufficient levels (50.0-74.9 nmol/l) and 27.4% had optimal levels (⩾75.0 nmol/l). Maternal 25(OH)D levels were not consistently associated with childhood combined kidney volume. Higher maternal 25(OH)D levels were associated with lower childhood eGFR (difference -0.94 ml/min per 1.73 m(2) (95% confidence interval, -1.73; -0.15) per 1 standard deviation (s.d.) increase in 25(OH)D). Maternal 25(OH)D levels were not associated with microalbuminuria. Cord blood 25(OH)D levels were not associated with childhood kidney outcomes. The associations of maternal 25(OH)D levels with childhood eGFR were partly explained by childhood vitamin D status.
Our findings suggest that maternal 25(OH)D levels during pregnancy may influence childhood kidney outcomes. These results should be considered hypothesis generating. Further studies are needed to replicate the observations, to examine the underlying mechanisms and to identify the long-term clinical consequences.
背景/目的:孕期母亲维生素D缺乏可能会影响子代肾脏健康。我们旨在研究胎儿期25-羟基维生素D(25(OH)D)血水平与学龄期肾脏结局之间的关联。
对象/方法:本研究纳入了一项基于人群的前瞻性队列研究中的4212对母婴。我们测量了母亲孕中期(18 - 25周)和胎儿脐带血(出生时)的25(OH)D水平。在儿童年龄中位数为6.0岁时,我们测量了儿童的双肾总体积、根据血清肌酐和胱抑素C水平计算的肾小球滤过率(eGFR)以及根据尿白蛋白和肌酐水平计算的微量白蛋白尿。
在所有母亲中,21.9%的母亲25(OH)D水平严重缺乏(<25.0 nmol/l),25.7%的母亲水平缺乏(25.0 - 49.9 nmol/l),25%的母亲水平充足(50.0 - 74.9 nmol/l),27.4%的母亲水平最佳(⩾75.0 nmol/l)。母亲的25(OH)D水平与儿童双肾总体积无一致关联。母亲25(OH)D水平较高与儿童较低的eGFR相关(25(OH)D每增加1个标准差,差异为-0.94 ml/min per 1.73 m(2)(95%置信区间,-1.73;-0.15))。母亲的25(OH)D水平与微量白蛋白尿无关。脐带血25(OH)D水平与儿童肾脏结局无关。母亲25(OH)D水平与儿童eGFR之间的关联部分可由儿童维生素D状态解释。
我们的研究结果表明,孕期母亲的25(OH)D水平可能会影响儿童肾脏结局。这些结果应视为提出假设。需要进一步研究来重复这些观察结果,研究潜在机制并确定长期临床后果。